| HS编码 | 商品名称 | 退税率 | 计量单位 | 海关监管 | 申报要素·检疫 | 编码对比 |
| 30024930.30 (增) | CAR-T细胞治疗药品生产用病毒载体
[Viral vectors for CAR-T cell therapy production] |
13% | 千克/株 | AB | 查看详情 | -- |
| 30021200.23 | 含有人类遗传资源的抗血清及其他血份
[Antiserum and other blood containing human genetic resources] |
13.0% | 千克/无 | ABV | 查看详情 | 对比-30024930.30 |
| 30021200.30 | 兽用血清制品
[Veterinary serum products] |
13 | 千克/无 | ABR | 查看详情 | 对比-30021200.23 |
| 30021200.93 | 罕见病药品制剂
[Rare disease drug preparation(Including the first and second batch of related products on the rare disease drug list)] |
13 | 千克/无 | AB | 查看详情 | 对比-30021200.30 |
| 30021200.94 | 其他含濒危动物成分的抗血清及血份
[Other antisera and other blood fractions of endangered ani-mals] |
千克/无 | ABEF | 查看详情 | 对比-30021200.93 | |
| 30021200.99 | 其他抗血清及其他血份
[Other anti-serum and other blood types due to the resolution of anti-cancer drugs] |
13.0% | 千克/无 | AB | 查看详情 | 对比-30021200.94 |
| 30021300.10 | 非混合的《兴奋剂目录》所列蛋白同化制剂和肽类激素免疫制品，未配定剂量或制成零售包装
[Non mixed protein assimilates and peptide hormone immune products listed in the "Catalogue of Doping Agents", without dosage or made into retail packaging] |
13% | 千克/无 | ABL | 查看详情 | 对比-30021200.99 |
| 30021300.90 | 其他非混合的免疫制品，未配定剂量或制成零售包装
[Other non mixed immune products, not formulated in dosage or made into retail packaging] |
13% | 千克/无 | AB | 查看详情 | 对比-30021300.10 |
| 30021400.00 | 混合的免疫制品，未配定剂量或制成零售包装
[Immunological products，mixed，not put up in measured doses or in forms or packings for retail sale] |
13% | 千克/无 | AB | 查看详情 | 对比-30021300.90 |
| 30021500.10 | 抗（防）癌药品制剂（不含癌症辅助治疗药品）
[Immunological products，put up in measured doses or in forms or packings for retail sale] |
13% | 千克/无 | AB | 查看详情 | 对比-30021400.00 |
| 30021500.30 | 罕见病药品制剂
[Rare disease drug preparations.] |
13% | 千克/无 | AB | 查看详情 | 对比-30021500.10 |
| 30021500.40 | 兽用免疫学体内诊断制品（已配剂量的）
[Veterinary immunology in vivo diagnostic products (with dosage already prepared)] |
13% | 千克/无 | ABR | 查看详情 | 对比-30021500.30 |
| 30021500.50 | 《兴奋剂目录》所列蛋白同化制剂和肽类激素免疫制品，已配定剂量或制成零售包装
[The protein assimilation agents and peptide hormone immune products listed in the "Catalogue of Doping Agents" have been formulated in doses or made into retail packaging] |
13% | 千克/无 | ABL | 查看详情 | 对比-30021500.40 |
| 30021500.90 | 其他免疫制品，已配定剂量或制成零售包装
[Immunological products，put up in measured doses or in forms or packings for retail sale] |
13% | 千克/无 | AB | 查看详情 | 对比-30021500.50 |
| 30024100.11 | 新型冠状病毒（COVID-19）疫苗，已配定剂量或制成零售包装
[The novel coronavirus (COVID-19) vaccine has been dosed or made into retail packaging] |
13% | 千克/无 | QAB | 查看详情 | 对比-30021500.90 |
| 30024100.19 | 新型冠状病毒（COVID-19）疫苗，未配定剂量或制成零售包装
[Novel coronavirus (COVID-19) vaccine, not dosed or made into retail packaging] |
13% | 千克/无 | QAB | 查看详情 | 对比-30024100.11 |
| 30024100.90 | 其他人用疫苗
[Others use vaccines] |
13% | 千克/无 | QAB | 查看详情 | 对比-30024100.19 |
| 30024200.00 | 兽用疫苗
[Veterinary vaccines] |
13% | 千克/无 | R | 查看详情 | 对比-30024100.90 |
| 30024920.00 | 蓖麻毒素
[Ricin toxin] |
13% | 千克/无 | 23Q | 查看详情 | 对比-30024200.00 |
| 30024930.10 | 两用物项管制细菌及病毒
[Dual use items control bacteria and viruses] |
13% | 千克/株 | 3AB | 查看详情 | 对比-30024920.00 |
